Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    OVER 100 NEW CYBERSECURITY GRADUATES READY TO COMBAT THE RISE IN CYBERCRIME IMPACTING BUSINESSES WORLDWIDE

    June 2, 2023

    The 14th International Infrastructure Investment and Construction Forum Kicks Off in Macao

    June 2, 2023

    Big tobacco’s big lie: Philip Morris’ smoke and mirrors strategy

    June 1, 2023
    Facebook Twitter Instagram
    Algeria News HubAlgeria News Hub
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Algeria News HubAlgeria News Hub
    Home » Hoth Therapeutics expands with Novel Alzheimer’s Treatment
    Health

    Hoth Therapeutics expands with Novel Alzheimer’s Treatment

    February 25, 2021
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Hoth Therapeutics, Inc., a biopharmaceutical company, announced it has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer’s disease.  

    Hoth also secured an exclusive license agreement with respect to the use of this drug for other indications. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is associated with the destruction of higher brain structures, such as those involved in memory and cognition. 

    The disease leads to deficits in cognitive function and declines in memory, learning, language, and in the ability to perform intentional and purposeful movements. The disease is predicted to increase at least threefold between 2000 and 2050, rendering AD a world-wide public health problem.

    
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth’s pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. 

    Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email

    Related Posts

    Big tobacco’s big lie: Philip Morris’ smoke and mirrors strategy

    June 1, 2023

    Unveiling the most overlooked early heart attack symptom

    June 1, 2023

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    May 30, 2023

    Resting heart rate: The overlooked metric in cardiac health assessment

    May 25, 2023

    HEAPS HEALTH enters the UAE Market in association with PRIME HEALTHCARE in Dubai

    May 25, 2023

    Global healthcare experts gather in Dubai for PMES 2023

    May 23, 2023
    Latest News
    Health

    Big tobacco’s big lie: Philip Morris’ smoke and mirrors strategy

    June 1, 2023

    In an ironic twist of self-serving rhetoric, Jacek Olczak, CEO of tobacco giant Philip Morris…

    Unveiling the most overlooked early heart attack symptom

    June 1, 2023

    Sony faces antitrust probe in Romania over PlayStation’s market dominance

    May 31, 2023

    Audio-Technica brings back the Sound Burger: a retro turntable for the modern age

    May 31, 2023

    From crisis to catastrophe: China’s potential 65 million COVID cases per week by June

    May 30, 2023

    Twitter’s legal woes mount as former PR firm files lawsuit for unpaid invoices

    May 30, 2023

    Global stocks surge as US debt ceiling agreement brings relief

    May 29, 2023

    India’s mastery in space: ISRO’s successful launch of Cartosat-3 satellite

    May 29, 2023
    © 2021 Algeria News Hub | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.